Projects per year
Search results
-
PBR28 PET
Masdeu, J. C., Appel, S. H., Faridar, A., Fujita, M., Karmonik, C., Nakawah, M. O. & Pascual, B.
6/7/16 → …
Project: Clinical Trial
-
Alzheimerâ??s Disease Neuroimaging Initiative 3 (ADNI3)
Masdeu, J. C., Nakawah, M. O. & Pascual, B.
9/15/16 → 7/31/22
Project: Federal Funding Agencies
-
Neuroimaging in AD
Masdeu, J. C., Faridar, A., Karmonik, C., Nakawah, M. O., Pascual, B., Roman, G. C., Taffet, G. & Toledo, J. B.
9/15/16 → …
Project: Clinical Trial
-
NMDA Receptor in Psychosis: Specific Auto-Antibodies
Masdeu, J. C., Faridar, A., Nakawah, M. O., Pascual, B. & Toledo, J. B.
11/14/16 → …
Project: Clinical Trial
-
LONGITUDINAL EARLY ONSET ALZHEIMERâ??S DISEASE (LEADS)
Masdeu, J. C., Faridar, A., Nakawah, M. O. & Pascual, B.
9/15/17 → 5/31/24
Project: Non Profit
-
Role of Brain Inflammation in Alzheimer’s Disease
Masdeu, J. C., Faridar, A., Fujita, M., Nakawah, M. O. & Pascual, B.
2/7/18 → …
Project: Clinical Trial
-
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer¿s Disease and Elevated Amyloid (A45 Trial) and in Subjects With Early Preclinical Alzheimer¿s Disease and Inter Amyloid (A3 Trial)
Masdeu, J. C., Toledo, J. B., Faridar, A. & Nakawah, M. O.
6/1/19 → 4/30/24
Project: Federal Funding Agencies
-
AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer¿s Disease and Elevated Amyloid (A45 Trial)
Masdeu, J. C., Toledo, J. B., Faridar, A. & Nakawah, M. O.
9/30/19 → 5/31/24
Project: Federal Funding Agencies
-
18F-MK-6240 Tau PET and Brain Inflammation in Alzheimer’s Disease
Masdeu, J. C., Faridar, A., Fujita, M., Nakawah, M. O., Pascual, B. & Roman, G. C.
10/29/19 → …
Project: Clinical Trial
-
Ocrelizumab for Psychosis by Autoimmunity (OPA)
Masdeu, J. C., Faridar, A., Madan, A., Nakawah, M. O., Pascual, B., Toledo, J. B. & Weinstein, B.
2/20/20 → …
Project: Clinical Trial
-
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Toledo, J. B., Faridar, A., Masdeu, J. C., Nakawah, M. O. & Pascual, B.
3/12/21 → …
Project: Clinical Trial
-
Houston Alzheimer Disease Study
Masdeu, J. C., Faridar, A., Fujita, M., Karmonik, C., Nakawah, M. O., Pascual, B., Roman, G. C., Toledo, J. B. & Wong, S. T.
5/17/21 → …
Project: Clinical Trial
-
Imaging for Precision Medicine in Alzheimer's Disease and Related Disorders
Masdeu, J. C., Faridar, A., Fujita, M., Karmonik, C., Nakawah, M. O., Pascual, B. & Roman, G. C.
5/25/22 → …
Project: Clinical Trial
-
TRACK-ALS-001
Masdeu, J. C., Appel, S. H., Nakawah, M. O., Pascual, B., Thonhoff, J. R. & Yu, M.
Project: Clinical Trial
-
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol (ADNI3)
Masdeu, J. C., Nakawah, M. O. & Pascual, B.
Project: Clinical Trial